BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1420 related articles for article (PubMed ID: 24691964)

  • 1. Erasers of histone acetylation: the histone deacetylase enzymes.
    Seto E; Yoshida M
    Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
    Christianson DW
    Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on lysine deacylases targeting the expanding "acylome".
    Olsen CA
    ChemMedChem; 2014 Mar; 9(3):434-7. PubMed ID: 24375937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
    Lombardi PM; Cole KE; Dowling DP; Christianson DW
    Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylases: salesmen and customers in the post-translational modification market.
    Brandl A; Heinzel T; Krämer OH
    Biol Cell; 2009 Apr; 101(4):193-205. PubMed ID: 19207105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
    Trapp J; Jung M
    Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H4 lysine 16 acetylation regulates cellular lifespan.
    Dang W; Steffen KK; Perry R; Dorsey JA; Johnson FB; Shilatifard A; Kaeberlein M; Kennedy BK; Berger SL
    Nature; 2009 Jun; 459(7248):802-7. PubMed ID: 19516333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
    Riester D; Wegener D; Hildmann C; Schwienhorst A
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
    Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
    Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of protein lysine deacetylation.
    Ellis DJP; Yuan Z; Seto E
    Curr Protoc Protein Sci; 2008 Nov; Chapter 14():14.12.1-14.12.14. PubMed ID: 19016433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs.
    McClure JJ; Inks ES; Zhang C; Peterson YK; Li J; Chundru K; Lee B; Buchanan A; Miao S; Chou CJ
    ACS Chem Biol; 2017 Jun; 12(6):1644-1655. PubMed ID: 28459537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation.
    Celic I; Masumoto H; Griffith WP; Meluh P; Cotter RJ; Boeke JD; Verreault A
    Curr Biol; 2006 Jul; 16(13):1280-9. PubMed ID: 16815704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.